The effectiveness of using Surgicel in reducing bleeding in patients undergoing prostatectomy

Evaluation of the effectiveness of using Surgicel in reducing bleeding in patients undergoing suprapubic simple open prostatectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200825048515N47

Enrollment

Registered

2021-10-29

Start date

2021-11-21

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suprapubic simple open prostatectomy. Erectile dysfunction following simple prostatectomy

Interventions

Intervention 1: Intervention group: In this surgical group, suprapubic simple open prostatectomy will be performed according to standard techniques, but after removing the prostate adenoma inside the

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Candidate patients for suprapubic simple open prostatectomy Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: History of any prostate surgery Consumption of anti-platelets and anticoagulants History of hereditary bleeding diseases

Design outcomes

Primary

Measure	Time frame
Hemoglobin. Timepoint: Before surgery, immediately, 24 and 48 hours after surgery. Method of measurement: Blood test.;Hematocrit. Timepoint: Before surgery, immediately, 24 and 48 hours after surgery. Method of measurement: Blood test.	—

Secondary

Measure	Time frame
Bleeding volume. Timepoint: During and after surgery. Method of measurement: The amount of blood sucked.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Kazemi

Esfahan University of Medical Sciences

dr.rezakazemi6788@gmail.com+98 31 3222 2127

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026